COVID vaccine

Bio & Pharma SK Bioscience, Sanofi to develop next-gen pneumococcal vaccines

South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...

IPOs Sono International seeks IPO in 2025 with $2.1 billion in corporate value

South Korea’s top resort operator Sono International Co. is seeking an initial public offering of its shares on the Korean market next year, r...

Bio & Pharma SK Bioscience's SKYCellflu approved in Indonesia

SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...

Korean startups Enormous market ahead for Hopae, S.Korean DID pioneer

To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...

Bio & Pharma SK Bioscience sells stake in US vaccine developer Novavax

SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...

Mergers & Acquisitions SK Bioscience to buy German vaccine maker IDT Biologika for $244 mn

South Korea’s vaccine developer SK Bioscience Co. will acquire a controlling stake in the world’s top 10 vaccine firm IDT Biologika GmbH...

Bio & Pharma EuBiologics gets WHO certification for cholera vaccine facility

South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vacc...

Travel & Leisure S.Korea sees record-high foreign visitors after pandemic

South Korea saw a record-high number of foreign tourists post-COVID-19 in the first quarter of 2024. The South Korean Ministry of Culture, Spor...

Bio & Pharma SK Bioscience exports Sky Cellflu to Thailand

South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured ...

Travel & Leisure Number of foreign tourists visiting Korea surpasses 11 million in 2023

The number of foreign tourists visiting Korea last year exceeded 11 million, reaching 63% of the pre-COVID level, with over 1 million arrivals month...

Bio & Pharma SK Bioscience start to deliver Novavax COVID-19 vaccine

South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...

Bio & Pharma SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

Bio & Pharma Korea to invest $200 mn in new drugs, vaccines by 2028

South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...

Bio & Pharma GC Biopharma wins $10 mn order for flu vaccine in Thailand

South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...

Bio & Pharma KAIST, IVI to collaborate on global vaccine research

The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...

Bio & Pharma SK Bioscience to develop 2nd-generation Ebola vaccine

South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...

Food & Beverage Korea Post resumes kimchi delivery to US

South Korea's state-run postal service agency Korea Post announced on Monday it resumed Express Mail Service (EMS) for shipping kimchi all over the ...

Travel & Leisure S.Korea releases winter schedule for weekly int’l flights

South Korea will expand its number of weekly flights this winter to Japan and Southeast Asia, two regions expected to have high demand that season, ...

Travel & Leisure S.Korean airlines see 12.87 mn int’l passengers in Q3 2023

South Korean airlines’ international passenger traffic in the third quarter reached 85% of that over the same period in 2019, the year befor...

Bio & Pharma S.Korean vaccine developer Quratis eyes Iraqi market

South Korean vaccine developer Quratis Inc. on Wednesday announced its signing of a term sheet on the direction and major transaction terms of coope...

Airlines Incheon Airport’s cumulative passengers surpass 800 mn

Incheon International Airport, which opened in 2001, has surpassed a cumulative total of 800 million passengers. Incheon International Airport Corpo...

E-commerce Live commerce app Grip aims to expand into Japan, US in 2024

Imagine you're using a shopping app. You talk to the seller, ask questions and receive answers in real-time on a livestream video. Now and then, the...

Airlines Eastar Jet resumes int'l flights after three and half years

South Korea's low-cost carrier Eastar Jet on Sunday said it resumed international flights for the first time in three and a half years starting with...

Beauty & Cosmetics LG H&H's The Whoo unveils Cheongidan renewal line in Shanghai

LG H&H Co. announced on Thursday its strategy to focus on the Chinese market by unveiling a renewal version of "Cheongidan," the flagship produc...

Travel & Leisure Foreign visitors to S.Korea in July surpass 1 mn post-COVID-19

The number of foreign tourists visiting South Korea has exceeded 1 million in a month for the first time since the outbreak of COVID-19. According t...

Bio & Pharma EuBiologics, GC Biopharma to jointly produce cholera vaccine

South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...

Bio & Pharma POSCO Int'l marks 1st animal vaccine exports

POSCO International Corp., the general trading and energy exploration unit of South Korea's steel giant POSCO Holdings Inc., announced on Thursday t...

Bio & Pharma SK Bioscience resumes output of flu vaccine after two years

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, on Wednesday shipped SKYCellflu, its vaccine for the common flu, for the fi...

Bio & Pharma SK Bioscience to export $51 bn flu vaccine to Thailand

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...

Bio & Pharma SK Bioscience buys 6.5 million Novavax shares for $83.4 million

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...